Citi raised its price target on Lam Research (LRCX) by $135, citing a multi-year chip manufacturing investment boom...
Citi raised its price target on Lam Research (LRCX) by $135, citing a multi-year chip manufacturing investment boom Source 3. This positive revision reflects strong demand for wafer fabrication equipment as semiconductor manufacturers expand capacity. LRCX's 10-Q filed on April 23, 2026, showed revenue of $13.26B and net income of $3.64B Source 1, indicating solid financial health. The analyst upgrade points to sustained capital expenditure by customers, benefiting equipment suppliers like Lam Research.
LRCX has already moved up +79% over the recent 30-90 day window.
signal brief
Citi raised its price target on Lam Research (LRCX) by $135, citing a multi-year chip manufacturing investment boom Source 3. This positive revision reflects strong demand for wafer fabrication equipment as semiconductor manufacturers expand capacity. LRCX's 10-Q filed on April 23, 2026, showed revenue of $13.26B and net income of $3.64B Source 1, indicating solid financial health. The analyst upgrade points to sustained capital expenditure by customers, benefiting equipment suppliers like Lam Research.
evidence
- https://data.sec.gov/api/xbrl/companyfacts/CIK0000707549.jsonedgar
- https://investor.lamresearch.comweb
- https://finance.yahoo.com/technology/articles/lam-research-lrcx-citi-raises-102212911.htmlweb
- https://baijiahao.baidu.com/s?id=1869429413148041015web
- https://www.news.cn/fortune/20260630/c1b30ba69e3b4e5288b2f6c2735cb5f1/c.htmlweb
- http://www.malaysiasun.com/news/279157183/cu-medicine-ranked-world-no-2-in-gastroenterology-hepatologyweb
- http://www.asiabulletin.com/news/279157183/cu-medicine-ranked-world-no-2-in-gastroenterology-hepatologyweb
- http://www.vietnamtribune.com/news/279157183/cu-medicine-ranked-world-no-2-in-gastroenterology-hepatologyweb
- https://www.nbd.com.cn/articles/2026-06-30/4442111.htmlweb
- https://www.manilatimes.net/2026/06/30/tmt-newswire/pr-newswire/cu-medicine-ranked-world-no-2-in-gastroenterology-hepatology/2375543web
- https://baomoi.com/nghi-quyet-10-nq-tw-va-buoc-chuyen-chien-luoc-tu-duy-bai-4-kien-tao-cuc-tang-truong-moi-tu-cu-hich-kep-c55512790.epiweb
- https://portal.sina.com.hk/finance/finance-prnewswire/prnasia/2026/06/30/1839612/cu-medicine-ranked-world-no-2-in-gastroenterology-hepatology/web
spillover entities
Decision support, not stock advice. This signal is research with cited evidence — not a recommendation to buy, sell, or hold any security.